CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

Medical Coverage Policy | Electrogastrography (EGG)

Defines coverage stance for electrogastrography (cutaneous/transcutaneous EGG) for Medicare Advantage and commercial products, including coding guidance and rationale based on insufficient evidence.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyMedical Coverage Policy | Electrogastrography (EGG)

Policy CodePolicy N/A

Change TypeNo material change

Effective DateApr 1, 2001

Next Review Date

Key ActionVerify member benefits and refer to the applicable Benefit Booklet, Evidence of Coverage, or Subscriber Agreement as benefits may vary between groups and contracts.

SourceLink

POLICY UPDATE CHANGES

No material changes to clinical evidence or coverage determinations.

2CPT codes listed as not covered

2001-04-01Effective date

2022-04-06Last policy update

Coverage Summary

Scope: Defines coverage stance for electrogastrography (cutaneous/transcutaneous EGG) for Medicare Advantage and commercial products, including coding guidance and rationale based on insufficient evidence.

Coverage stance: Not covered / Not medically necessary for Electrogastrography (EGG) as applied to cutaneous/transcutaneous recordings of gastric electrical activity; the policy applies to Medicare Advantage and Commercial Products and lists relevant CPT coding guidance. Effective date: 2001-04-01; Last review: 2022-04-06.

Coverage Determinations / Criteria

Medicare Advantage Coverage Determination

Covered when ALL of the following are met:

Electrogastrography is not covered for Medicare Advantage Plans because the evidence is insufficient to determine the effects of the technology on health outcomes.

Commercial Products Coverage Determination

Covered when ALL of the following are met:

Electrogastrography is not medically necessary for Commercial Products because the evidence is insufficient to determine the effects of the technology on health outcomes.

Not Medically Necessary / Not Covered

Rationale: Published peer-reviewed literature and professional guidance were reviewed and found inadequate to establish technical validity, diagnostic accuracy, or impact on patient management; therefore electrogastrography is considered not medically necessary.

Evidence basis: EGG shows a poor correlation with scintigraphic gastric emptying tests and other reference standards, lacks adequate sensitivity/specificity and outcome data demonstrating clinical utility, and professional guidance (American Gastroenterological Association) did not recommend EGG for routine testing of gastric myoelectrical activity; scintigraphic gastric emptying remains the gold standard for evaluation of gastroparesis.

Provider Actions

Documentation Required

Benefit verification

Verify member benefits and refer to the applicable Benefit Booklet, Evidence of Coverage, or Subscriber Agreement as benefits may vary between groups and contracts.

Denial Risk

Claim denial / not medically necessary

Claims for electrogastrography may be denied as not covered / not medically necessary for Medicare Advantage and Commercial Products per this policy.

91132
91133

Background & Evidence

Electrogastrography (EGG) records cutaneous gastric electrical activity, broadly capturing electrical control activity (ECA) and electrical response activity (ERA) using surface electrodes positioned on the abdominal wall.

EGG measurement is challenged by relatively weak cutaneous signals and background noise from cardiac, respiratory, duodenal, and colonic activity, which complicates direct visual analysis and has led to reliance on filtering and automated spectral analysis methods.

EGG has been most studied in gastroparesis and functional dyspepsia, but several studies report poor correlation with scintigraphic gastric emptying, and scintigraphic gastric emptying—using a radiolabeled solid meal with serial imaging—is considered the gold standard for diagnosing delayed gastric emptying.

Source	Summary
Professional guidance	American Gastroenterological Association position (2004) discussed but did not recommend use of EGG for gastric myoelectrical activity; published guidance and literature do not support clinical utility.
Correlation with gold standard	Several studies reported poor correlation between EGG and gastric emptying tests; scintigraphic gastric emptying remains the gold standard (delayed emptying defined as >50% retention at end of study).

Gastroparesis: A chronic disorder of gastric motility evidenced by delayed gastric emptying of a solid meal; symptoms include bloating, distention, nausea, and vomiting.

Electrical control activity (ECA): Regularly recurring gastric electrical potentials originating in the gastric pacemaker; not associated with contractions unless coupled with ERA.

Electrical response activity (ERA): Action potentials associated with contractions of the stomach when coupled with ECA.

Revision History

2001-04-01effective_date

Policy effective date (Electrogastrography).

2022-04-06last_reviewLatest

Policy last updated; electrogastrography not covered for Medicare Advantage and not medically necessary for Commercial Products due to insufficient evidence.